Abbott and Sanofi Announce Partnership to Integrate Glucose Monitoring and Insulin Delivery Devices

Text Size:
Abbott and Sanofi Announce Partnership to Integrate Glucose Monitoring and Insulin Delivery Devices

In the latest example of the trend toward greater collaboration among diabetes device makers in recent years, two of the biggest names in diabetes care — Abbott and Sanofi — have announced a new partnership focused on integrating glucose sensing and insulin delivery technologies.

To get cutting-edge diabetes news, strategies for blood glucose management, nutrition tips, healthy recipes, and more delivered straight to your inbox, sign up for our free newsletter!

The two companies announced in a joint press release that they will develop tools to combine Abbott’s FreeStyle Libre continuous glucose monitoring (CGM) system with insulin dosing information on Sanofi’s future smart pens, insulin dosing apps and cloud-based software systems. The non-exclusive collaboration will allow users to enable data sharing between Abbott and Sanofi devices, allowing them to be be seamlessly integrated.

The announcement means that once new integration-cable Sanofi insulin delivery devices are released, current Freestyle Libre users may want to switch to using them. It also means that people who currently use Sanofi insulin products and like them may want to use the Freestyle Libre if they’re considering starting on a CGM system, knowing that the two ecosystems will soon be compatible.

“We see a significant opportunity to impact the health of millions of people living with diabetes by developing new tools and connectivity with Sanofi,” says Jared Watkin, senior vice president of Diabetes Care at Abbott, in the announcement. “Building a digital ecosystem around FreeStyle Libre simplifies the user experience.”

The new partnership “is representative of the next evolution of our commitment for better diabetes care by incorporating digital tools into the daily life of people living with diabetes,” adds Gustavo Pesquin, senior vice president of Global Diabetes and Cardiovascular Franchise at Sanofi. “By partnering with Abbott, we are a step closer to realizing our connected ecosystem.”

Want to learn more about continuous glucose monitoring? Read “CGM for Diabetes Management” and “Sensing the Big Picture With Continuous Glucose Monitoring,” then watch the video “Continuous Glucose Monitoring.”

Quinn PhillipsQuinn Phillips

A freelance health writer and editor based in Wisconsin, Phillips has a degree in government from Harvard University. He writes on a variety of topics, but is especially interested in the intersection of health and public policy.

Get Diabetes-Friendly Recipes In Your Inbox

Sign up for Free

Stay Up To Date On News & Advice For Diabetes

Sign up for Free

Get On Track With Daily Lifestyle Tips

Sign up for Free

Save Your Favorites

Save This Article